United Bank (Georgia)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$552K Hold
2,192
0.17% 90
2026
Q1
$477K Buy
2,192
+839
+62% +$186K 0.16% 100
2025
Q4
$309K Buy
1,353
+254
+23% +$57.9K 0.1% 107
2025
Q3
$254K Sell
1,099
-300
-21% -$61.1K 0.09% 109
2025
Q2
$260K Hold
1,399
0.1% 104
2025
Q1
$293K Hold
1,399
0.12% 97
2024
Q4
$249K Buy
1,399
+300
+27% +$55.2K 0.11% 99
2024
Q3
$217K Buy
+1,099
New +$205K 0.1% 98
2024
Q2
Sell
-1,099
Closed -$200K 95
2024
Q1
$200K Buy
+1,099
New +$189K 0.1% 93

Other funds holding ABBV

United Bank (Georgia)'s ABBV Position: Q2 2026 in Review

United Bank (Georgia) held its AbbVie (ABBV) position steady in Q2 2026 at 2,192 shares worth $552K. The position accounts for 0.17% of the portfolio, ranked #90.

United Bank (Georgia) first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • United Bank (Georgia) held 2,192 shares of AbbVie worth $552K as of Q2 2026.
  • United Bank (Georgia) left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.17% of United Bank (Georgia)'s portfolio in Q2 2026, its #90 holding.
  • United Bank (Georgia) first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on United Bank (Georgia)'s 13F filing for Q2 2026, filed 10 Aug 2026.